- Pharma-Bio Serv, Inc. reported **revenues of approximately $2.0 million** for the three months ended July 31, 2025, and **$6.9 million** for the nine months ended July 31, 2025.  **[1304161_0001654954-25-010776_pbsv_ex991.htm:0]**  These figures are a decrease from **$2.4 million** and **$7.2 million**, respectively, in the same periods last year.  **[1304161_0001654954-25-010776_pbsv_ex991.htm:0]** 
- The company posted a **net loss of approximately $0.2 million** for the three months ended July 31, 2025, and a **net loss of approximately $0.1 million** for the nine months ended July 31, 2025.  **[1304161_0001654954-25-010776_pbsv_ex991.htm:0]**  This represents an **earnings increase of $0.1 million and $0.7 million**, respectively, compared to the prior year periods.  **[1304161_0001654954-25-010776_pbsv_ex991.htm:0]** 
- CEO Mr. Sanchez stated that the company has streamlined its cost structure, prioritized core business segments, and is preparing for the **immediate commencement of several significant projects**.  **[1304161_0001654954-25-010776_pbsv_ex991.htm:0]**

Pharma-Bio Serv (PBSV)